Large-scale testing (Phase 3)Study completedNCT03562195What this trial is testingA Safety and Efficacy Study of Mepolizumab in Subjects With Severe AsthmaWho this might be right forAsthma GlaxoSmithKline 300
Not applicableStudy completedNCT05734339What this trial is testingPatient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)Who this might be right forAsthma AstraZeneca 43
Large-scale testing (Phase 3)Study completedNCT02869438What this trial is testingEvaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic InflammationWho this might be right forAsthma AstraZeneca 233
Not applicableEnded earlyNCT00509197What this trial is testingShould Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?Who this might be right forAsthma Université de Montréal 12
Large-scale testing (Phase 3)Study completedNCT02555371What this trial is testingCessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsWho this might be right forAsthma GlaxoSmithKline 306
Not applicableUnknownNCT05365841What this trial is testingRole of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).Who this might be right forSevere Eosinophilic Asthma w/wo CRSwNP University of Crete 85
Not applicableStudy completedNCT05091333What this trial is testingFASENRA Regulatory Postmarketing Surveillance in KoreaWho this might be right forAsthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis) AstraZeneca 51
Testing effectiveness (Phase 2)Study completedNCT05985694What this trial is testingAD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic AsthmaWho this might be right forEosinophilic Asthma Advagene Biopharma Co. Ltd. 40
Large-scale testing (Phase 3)Study completedNCT05083312What this trial is testingEfficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 TrialWho this might be right forEosinophilic Esophagitis Ellodi Pharmaceuticals, LP 6
Post-approval studies (Phase 4)Study completedNCT01171365What this trial is testingSmall Particle Steroids in Refractory AsthmaWho this might be right forAsthma University of Nottingham 30
Not applicableNot Yet RecruitingNCT07174713What this trial is testingREverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)Who this might be right forAsthma; Eosinophilic Western University, Canada 200
Not applicableUnknownNCT04650503What this trial is testingFollow-up of Mild Eosinophilic AsthmaWho this might be right forAsthma Laval University 80
Not applicableNot Yet RecruitingNCT07602881What this trial is testingBlood Exosomal Multi-omics and Lung Radiomics for Predicting Efficacy and Prognosis of Severe Eosinophilic ACOS With BiologicsWho this might be right forSevere Eosinophilic ACOS (Asthma-COPD Overlap) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 500
Not applicableStudy completedNCT03453021What this trial is testingEffect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic AsthmaWho this might be right forAsthma; Eosinophilic University Hospital, Grenoble 27
Not applicableUnknownNCT04414137What this trial is testingDescription of Eosinophilic Pneumonia in BJI/PJI Treated by DaptomycinWho this might be right forDactinomycin Adverse ReactionBone and Joint Infection Hospices Civils de Lyon 20
Not applicableStudy completedNCT05180357What this trial is testingRANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.Who this might be right forSevere Eosinophilic AsthmaNasal Polyps AstraZeneca 273
Post-approval studies (Phase 4)Study completedNCT00632554What this trial is testingThe Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic PneumoniaWho this might be right forEosinophilic PneumoniaChronic Disease Hamamatsu University 50
Large-scale testing (Phase 3)Ended earlyNCT01290887What this trial is testingOpen-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaWho this might be right forEosinophilic Asthma Teva Branded Pharmaceutical Products R&D, Inc. 1,052
Not applicableStudy completedNCT03696914What this trial is testingIntense Airway Eosinophilia in AsthmaWho this might be right forAsthmaEosinophilic Asthma Laval University 918
Post-approval studies (Phase 4)Ended earlyNCT02937168What this trial is testingAn Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway InflammationWho this might be right forAsthma Teva Branded Pharmaceutical Products R&D, Inc. 5